Kansas City Urology Care, PA

Overland Park, Kansas 66211

0 studies enrolling now · 8 studies all time

What they study most

Adenocarcinoma of the Prostate, Bladder Cancer, Bladder Neoplasm, Cancer of the Prostate, Carcinoma in Situ, Castration-Resistant Prostate Cancer, Hormone Sensitive Prostate Cancer, Mycobacterium, Neoplasm Recurrence, Local, Nonmetastatic Castration-Resistant Prostate Cancer, Peyronie's Disease, Prostate Cancer

Studies at this site

• Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK) — Running, not enrolling
• Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer — Completed
• Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer — Completed
• Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-611) — Completed
• Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer — Stopped early
• Long-term Safety, Curvature Deformity Characterization, and Immunogenicity Over Time in Subjects Previously Treated With AA4500 for Peyronies Disease — Completed
• Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer — Stopped early
• A Trial of Degarelix in Patients With Prostate Cancer — Completed